|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.330 USD | -1.48% |
|
-3.62% | -10.74% |
| 11-14 | Marker Therapeutics Q3 net loss narrows to $2 mln | RE |
| 11-13 | Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.48% | -3.62% | -6.99% | -9.52% | -10.74% | +7.69% | -30.00% | -93.14% | -98.21% | 22.18M | |
| -0.72% | -4.60% | -7.68% | -6.57% | -10.56% | -12.29% | -8.00% | -11.90% | +205.20% | 42.78B | |
| -0.44% | -5.67% | -17.92% | -10.97% | -6.50% | +9.59% | +22.80% | -11.70% | +952.04% | 31.5B | |
| -0.24% | -3.29% | -13.66% | +10.01% | +13.54% | +14.84% | +48.71% | -19.85% | +162.75% | 29.99B | |
| +1.10% | -5.60% | -1.33% | -25.89% | -26.92% | -11.05% | -17.93% | -11.82% | +146.48% | 27.65B | |
| -0.22% | -3.60% | -1.51% | +20.20% | +19.10% | +142.48% | +304.69% | +99.41% | - | 18.8B | |
| -1.32% | -6.10% | +4.47% | +2.52% | +5.97% | +47.72% | +106.64% | +51.41% | +1,127.49% | 13.87B | |
| +1.48% | -4.29% | +5.23% | -19.27% | -19.81% | +38.61% | +148.23% | +181.51% | - | 12.78B | |
| -0.29% | -4.80% | -6.08% | +6.59% | -1.47% | +24.93% | +0.10% | -19.04% | +93.61% | 12.39B | |
| -1.59% | -3.85% | -11.67% | -11.92% | -10.01% | +115.99% | +110.87% | +34.35% | +76.47% | 11.76B | |
| -3.21% | -0.51% | -25.59% | +39.94% | +10.62% | +6,894.88% | +3,230.94% | - | - | 11.49B | |
| -1.56% | +7.66% | -4.71% | -6.47% | -15.95% | +1,753.48% | +1,578.28% | +411.11% | +622.34% | 9.01B | |
| +0.91% | -4.36% | -3.79% | -29.22% | -15.36% | +5.96% | - | - | - | 8.94B | |
| +0.14% | -.--% | -.--% | -.--% | -.--% | +44.52% | +179.25% | +20.58% | +627.71% | 8.38B | |
| -1.26% | -8.87% | -19.46% | -14.71% | -14.23% | -2.30% | -21.51% | -24.68% | +56.51% | 8.37B | |
| -3.11% | -5.39% | -7.34% | +9.36% | -0.27% | +667.89% | +1,634.22% | -55.76% | - | 8.19B | |
| -1.20% | -5.64% | -15.15% | -13.09% | -13.54% | -18.19% | -30.60% | -47.19% | +115.74% | 7.96B | |
| +1.83% | -10.89% | -3.65% | -19.46% | -22.07% | -9.11% | -24.17% | -45.79% | +110.39% | 7.65B | |
| +0.90% | -8.27% | +5.73% | -47.30% | -46.04% | -46.73% | -54.32% | -46.06% | +34.98% | 7.51B | |
| -2.04% | +1.61% | -7.06% | -7.09% | -2.25% | +0.25% | -25.89% | -47.58% | - | 6.84B | |
| Average | -0.62% | -3.76% | -6.91% | -6.64% | -8.32% | +483.46% | +376.44% | +20.21% | +302.39% | 14.29B | |
| Weighted average by Cap. | -0.45% | -3.80% | -7.69% | -5.23% | -6.51% | +369.88% | +277.22% | +19.16% | +359.92% |
- Stock Market
- Equities
- MRKR Stock
- Sector Marker Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition